The cGAS-STING signaling is a key regulator in immune responses and plays a vital role in BRCA development and progression (Hong et al., 2022), but little is known about the role of cGAS-STING-related genes (CSRGs) in the clinical pathogenesis of breast cancer. This evidence concerns the gene STING1 and breast cancer.